Nkhani ya Gentolex ingayambike m'chilimwe cha 2013, gulu la achinyamata omwe ali ndi masomphenya m'makampani kuti apange mwayi wogwirizanitsa dziko lapansi ndi ntchito zabwino komanso chitsimikizo cha mankhwala.
Malo onse omanga fakitale a 250,000 masikweya mita pansi pa muyezo wapadziko lonse lapansi kuti apereke mayankho osinthika, owopsa komanso otsika mtengo.
Gentolex imapereka ma API ambiri komanso apakatikati pakuphunzira kwachitukuko ndi kugwiritsa ntchito malonda ndi cGMP muyezo kuchokera ku mgwirizano wautali.Zolemba ndi Zikalata zimathandizidwa kwa makasitomala padziko lonse lapansi.
Tili ndi chidziwitso chochuluka chopereka ntchito za CRO ndi CDMO panthawi yonse yachitukuko cha mankhwala a peptide pama projekiti a IND, NDA & ANDA, amapereka chitsogozo chotetezeka komanso choyenera kuyambira pachitukuko mpaka kupanga malonda.
Kwa makasitomala omwe amakonda kupewa zovuta zokumana nazo zingapo, timapereka ntchito zogulira makonda zomwe zili ndi magwero apamwamba kwambiri komanso okwanira.
Nkhani ya Gentolex ingayambike m'chilimwe cha 2013, gulu la achinyamata omwe ali ndi masomphenya m'makampani kuti apange mwayi wogwirizanitsa dziko lapansi ndi ntchito zabwino komanso chitsimikizo cha mankhwala.Mpaka pano, pokhala ndi zaka zambiri, Gentolex Group yakhala ikutumikira makasitomala ochokera kumayiko oposa 15 m'mayiko onse a 5, makamaka, magulu oimira akhazikitsidwa ku Mexico ndi South Africa, posachedwa, magulu oimira ambiri adzakhazikitsidwa ntchito zamalonda.
Pa 2021-12-06, nthawi yaku US, Acadia Pharmaceuticals (Nasdaq: ACAD) adalengeza zotsatira zabwino zapamwamba za mayeso ake azachipatala a Phase III omwe adafuna kumwa mankhwala, Trofinetide.Muyeso wa gawo III, wotchedwa Lavender, umagwiritsidwa ntchito makamaka kuyesa chitetezo ndi mphamvu ya Trofinetide pochiza Ret...
Pofika chaka cha 2021-08-24, Cara Therapeutics ndi mnzake wa bizinesi Vifor Pharma adalengeza kuti kappa opioid receptor agonist difelikefalin (KORSUVA™) adavomerezedwa ndi FDA pochiza odwala matenda a impso (CKD) (zabwino Pakatikati/zotupa kwambiri ndi hemod...
Canada nthawi 2022-01-24, RhoVac, kampani mankhwala lolunjika pa chotupa immunology, analengeza kuti patent ntchito (No. 2710061) kwa khansa peptide katemera RV001 adzakhala ovomerezeka ndi Canadian Intellectual Property Office (CIPO).M'mbuyomu, kampaniyo idapeza ma patent okhudzana ndi ...